VIVACELL BIOTECHNOLOGY ESPANA S L has a total of 23 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2007. It filed its patents most often in Brazil, Canada and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and chemical engineering are GMEINER PETER, NEUROTECH CO LTD and SHAN DONG LUYE PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 3 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Mexico | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Australia | 1 | |
#8 | China | 1 | |
#9 | Spain | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Acyclic or carbocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Steroids | |
#5 | Medical preparations | |
#6 | Organic chemistry methods | |
#7 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Appendino Giovanni | 17 |
#2 | Munoz Blanco Eduardo | 10 |
#3 | Bellido Cabello De Alba Maria Luz | 9 |
#4 | Minassi Alberto | 9 |
#5 | Giovanni Appendino | 6 |
#6 | Eduardo Muñoz Blanco | 6 |
#7 | María Luz Bellido Cabello De Alba | 6 |
#8 | Bellido Cabello De Alba María Luz | 6 |
#9 | Muñoz Blanco Eduardo | 5 |
#10 | Alberto Minassi | 3 |
Publication | Filing date | Title |
---|---|---|
AU2017341257A1 | Hydroxamate triterpenoid derivatives | |
KR20160146765A | Novel cannabidiol quinone derivatives | |
EP2913321A1 | Novel cannabigerol derivatives | |
ES2408507A1 | INGENOL INSULATION METHOD. | |
WO2011117429A1 | Cannabinoid quinone derivatives | |
EP2044935A1 | A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases |